Gachon University Gil Medical Cneter
Incheon, South Korea
NCT Number: NCT01920542
we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients
Looking for future studies?
Notify Me1 year–6 year
All sexes
Interventional
Not applicable
Incheon, South Korea
dexmedetomidine, a2-adrenoreceptor agonist has been used for sedation or hemodynamic stability for operative procedure. It had been already reported that dexmedetomidine reduce the impairment of renal functon after cardiac operation in adult. we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
administration of dexmedetomidine on dexemedetomidine group
Other names: administration of dexmedetomidine
no administration of dexmedetomidine on control group
Other names: no administration of dexmedetomidine
Time frame: from anesthetic induction up to postoperative 2h
at immediate after anesthetic induction (baseline), after weaning of cardiopulmonary bypass, 2h after end of operationCPB, sodium and creatinine in the urine and serum, N-acetyl-b-glucosaminidase (NAG)and albumin in only urine could be studied
Gachon University Gil Medical Center
Other
Renal Effects of Dexmedetomidine During Pediatric Cardiac Surgery: a Randomized Placebo-controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05186636
Acute Kidney Injury, Acute Renal Injury
Calgary, Alberta, Canada
View Trial DetailsNCT05970952
Acute Kidney Injury, Acute Renal Injury
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05384899
Acute Kidney Failure, Acute Kidney Injury
New Haven, Connecticut, United States
View Trial DetailsNCT05145283
Acute Ischemic Stroke, Acute Kidney Injury
Basel, Switzerland
View Trial Details